Jeff Dallager, VP and Corporate Controller at ST JUDE MEDICAL INC (STJ), sold 501 shares at $60.94 ($31K) on 2015-12-21, disclosed to the SEC on 2015-12-22.
Scheduled sale ($31k) by VP and Corporate Controller under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| STJ | SELL | 2014-10-31 | $1.2M | — | Filing → |